Changing the composition of buffered eye-drops prevents undesired side effects

British Journal of Ophthalmology

Volumn 94, Issue 11, 2010, Pages 1519-1522

  Schrage, Norbert F ^a,b,c   Frentz, Markus ^b   Reim, Martin ^c  

^a KRANKENHAUS MERHEIM   (Germany)

^b Aachen Center of Technology Transfer in Ophthalmology   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; CITRIC ACID; EYE DROPS; HYALURONIC ACID; HYLO CARE; HYLO COMOD; HYLO LASOP; PHOSPHATE; POLYSPECTRAN; UNCLASSIFIED DRUG; BUFFER;

ANIMAL TISSUE; ARTICLE; CALCIFICATION; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; DRUG FORMULATION; EYE IRRITATION; NONHUMAN; PRIORITY JOURNAL; WOUND HEALING; ANIMAL; CALCINOSIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DRUG EFFECT; RABBIT;

ANIMALS; BUFFERS; CALCINOSIS; CORNEA; CORNEAL DISEASES; HYALURONIC ACID; OPHTHALMIC SOLUTIONS; RABBITS; WOUND HEALING;

EID: 78149478040     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.177386     Document Type: Article

References (18)

1. Langefeld S, Reim M, Redbrake C, et al. The corneal stroma, an inhomogenous structure. Graefes Arch Clin Exp Ophthalmol 1997;235:480-5.
2. von Fischern T, Lorenz U, Burchard WG, et al. Changes in the mineral composition of the rabbit cornea after alkali burns. Graefes Arch Clin Exp Ophthalmol 1998;236:553-8. (Pubitemid 28301569)
3. Huige WMM, Beekhuis WH, Rijnefeld WJ, et al. Deposits in the superficial corneal stroma after combined topical corticosteroid and beta-blocking medication. Eur J Ophthalmol 1991;1:198-9.
4. Bernauer W, Thiel MA, Kurrer M, et al. Corneal calcification following intensified treatment with sodium hyaluronate artificial tears. Br J Ophthalmol 2006;90:285-8.
5. Schrage NF, Schlossmacher B, Aschenbernner W, et al. Phosphate buffer in alkali eye burns as an inducer of experimental corneal calcification. Burns 2001;27:459-64.
6. Schrage NF, Kompa S, Ballmann B, et al. Relationship of eye burns with calcifications of the cornea? Graefes Arch Clin Exp Ophthalmol 2005;243:780-4.
7. Bernauer W, Thiel MA, Langenauer UM, et al. Phosphate concentration in artificial tears. Graefes Arch Clin Exp Ophthalmol 2006;244:1010-14.
8. HYLO-COMOD: citrate buffered hyaluronate artificial tears. Medical information, Ursapharm pharmazeutische Fabrik. Ursapharm Arzneimittel GmbH, 2007.
9. Stanley JA. Water permeability of the human cornea. Arch Ophthalmol 1992;87:568-73.
10. Leopold IH, Lieberman TW. Chemical injuries of the cornea. Fed Proc 1971;30:92-5.
11. Caldeira JA, Sabbaga E, Ianhez LE. Conjunctival and corneal changes in renal failure. Influence of renal transplantation. Br J Ophthalmol 1970;54:399-404.
12. Maurice DM. The tonicity of an eye drop and its dilution by tears. Exp Eye Res 1971;11:30-3.
13. Frentz M, Goss M, Reim M, et al. Repeated exposure to benzalkonium chloride in the Ex Vivo Eye Irritation Test (EVEIT): observation of isolated corneal damage and healing. ATLA 2008;36:25-32. (Pubitemid 351439796)
14. Spöler F, Frentz M, Först M, et al. Analysis of hydrofluoric acid penetration and decontamination of the eye by means of time-resolved optical coherence tomography. Burns 2008;34:549-55.
15. Spöler F, Först M, Kurz H, et al. Dynamic analysis of chemical eye burns using high-resolution optical coherence tomography. J Biomed Opt 2007;12:041203.
16. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005;112:654-9.
17. Luo L, Li DQ, Doshi A, et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Invest Ophthalmol Vis Sci 2004;45:4293-301. (Pubitemid 39564653)
18. Ebihara N, Funaki T, Takai S, et al. Tear chymase in vernal keratoconjunctivitis. Curr Eye Res 2004;28:417-20.